The effects on mucociliary clearance of prednisone associated with bronchial section


Autoria(s): de Oliveira Braga, Karina Andrighetti; Nepomuceno, Natalia Aparecida; Correia, Aristides Tadeu; Jatene, Fabio Biscegli; Pego-Fernandes, Paulo Manuel
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

31/10/2013

31/10/2013

2012

Resumo

OBJECTIVE: Infections have been and remain the major cause of morbidity and mortality after lung transplantation. Because mucociliary clearance plays an important role in human defense mechanisms, the influence of drugs on the mucociliary epithelium of patients undergoing lung transplantation must be examined. Prednisone is the most important corticosteroid used after lung transplantation. The aim of this study was to evaluate the effects of bronchial transection and prednisone therapy on mucociliary clearance. METHODS: A total of 120 rats were assigned to 4 groups according to surgical procedure or drug therapy: prednisone therapy (1.25 mg/kg/day); bronchial section and anastomosis + prednisone therapy (1.25 mg/kg/day); bronchial section + saline solution (2 ml/day); and saline solution (2 ml/day). After 7, 15, or 30 days, the animals were sacrificed, and the lungs were removed from the thoracic cavity. The in situ mucociliary transport velocity, ciliary beat frequency and in vitro mucus transportability were evaluated. RESULTS: Animals undergoing bronchial section surgery and anastomosis had a significant decrease in the ciliary beat frequency and mucociliary transport velocity 7 and 15 days after surgery (p<0.001). These parameters were normalized 30 days after the surgical procedure. Prednisone improved mucous transportability in the animals undergoing bronchial section and anastomosis at 15 and 30 days (p<0.05). CONCLUSION: Bronchial section and anastomosis decrease mucociliary clearance in the early postoperative period. Prednisone therapy improves mucus transportability in animals undergoing bronchial section and anastomosis.

Heart Institute, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Heart Institute, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, SP, Brazil

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, SP, Brazil

Identificador

CLINICS, SAO PAULO, v. 67, n. 6, supl., Part 3, pp. 647-651, AUG 16, 2012

1807-5932

http://www.producao.usp.br/handle/BDPI/37110

10.6061/clinics/2012(06)16

http://dx.doi.org/10.6061/clinics/2012(06)16

Idioma(s)

eng

Publicador

HOSPITAL CLINICAS, UNIV SAO PAULO

SAO PAULO

Relação

CLINICS

Direitos

openAccess

Copyright HOSPITAL CLINICAS, UNIV SAO PAULO

Palavras-Chave #PREDNISONE #MUCOCILIARY CLEARANCE #BRONCHI #LUNG TRANSPLANTATION #IMMUNOSUPPRESSION #LUNG TRANSPLANTATION #CYCLOSPORINE-A #BENZALKONIUM CHLORIDE #EPITHELIAL FUNCTION #AIRWAY MUCUS #NASAL-MUCOSA #TRANSECTION #RATS #CORTICOSTEROIDS #SECRETION #MEDICINE, GENERAL & INTERNAL
Tipo

article

original article

publishedVersion